Related Articles
Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
Interferons in Systemic Lupus Erythematosus
Current knowledge of receptor-ligand interactions, cell signaling, and transcriptional regulation derive from studies of type I interferon. The design of novel therapeutics is informed by the advances in investigation of type I interferon, with the potential for important impacts on patient management.
Systemic Lupus Erythematosus: A Complex, Multi-Challenging Disease
Reviewing the research presented at ACR Convergence 2024.
Genome-Wide Association Studies of SLE
What do these studies tell us about disease mechanisms in lupus?